TP53 and breast cancer: The current study revealed that 2,2-diphenethyl isothiocyanate (DPEITC) is a more potent synthetic analog that can inhibit the growth of different subtypes of BC cells, irrespective of p53 mutant-type, via mutant p53 rescue.